Clinical Trial Update: OKS for the Treatment of Hemispatial Neglect [NA]

View source ↗

Summary

A clinical trial evaluating OKS for the treatment of hemispatial neglect has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemispatial Neglect

Drugs mentioned

• OKS

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Neglect, Hemispatial, Neglect, Sensory | NA | Status: WITHDRAWN